Patients with PAD had a significantly higher IGFBP-7 concentration than the control group—1.80 ± 1.62 ng/mL vs. 1.41 ± 0.45 ng/mL, p = 0.04. This evidence concerns the gene IGFBP7 and peripheral arterial disease.